90 related articles for article (PubMed ID: 31594672)
1. Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma.
Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Quaglino P; Osella-Abate S; Cassoni P; Malvehy J; Carrera C; Pigem R; Barreiro-Capurro A; Requena C; Traves V; Manrique-Silva E; Fernández-Orland A; Ferrandiz L; García-Senosiain O; Fernández-Figueras MT; Ferrándiz C; Nagore E;
Eur J Surg Oncol; 2020 Feb; 46(2):263-271. PubMed ID: 31594672
[TBL] [Abstract][Full Text] [Related]
2. Complete lymph node dissection in cutaneous melanoma patients with positive sentinel lymph node: Outcome and predictors in a retrospective cohort study over 16 years.
Baecher H; Gerken M; Knoedler L; Knoedler S; Alfertshofer M; Klinkhammer-Schalke M; Berneburg M; Drexler K; Haferkamp S
J Plast Reconstr Aesthet Surg; 2024 May; 92():33-47. PubMed ID: 38489985
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
[TBL] [Abstract][Full Text] [Related]
4. Prediction of nonsentinel lymph node metastasis in acral melanoma with positive sentinel lymph nodes.
Lin X; Sun W; Ren M; Xu Y; Wang C; Yan W; Kong Y; Balch CM; Chen Y
J Surg Oncol; 2023 Dec; 128(8):1407-1415. PubMed ID: 37689989
[TBL] [Abstract][Full Text] [Related]
5. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
; Crystal JS; Thompson JF; Hyngstrom J; Caracò C; Zager JS; Jahkola T; Bowles TL; Pennacchioli E; Beitsch PD; Hoekstra HJ; Moncrieff M; Ingvar C; van Akkooi A; Sabel MS; Levine EA; Agnese D; Henderson M; Dummer R; Neves RI; Rossi CR; Kane JM; Trocha S; Wright F; Byrd DR; Matter M; Hsueh EC; MacKenzie-Ross A; Kelley M; Terheyden P; Huston TL; Wayne JD; Neuman H; Smithers BM; Ariyan CE; Desai D; Gershenwald JE; Schneebaum S; Gesierich A; Jacobs LK; Lewis JM; McMasters KM; O'Donoghue C; van der Westhuizen A; Sardi A; Barth R; Barone R; McKinnon JG; Slingluff CL; Farma JM; Schultz E; Scheri RP; Vidal-Sicart S; Molina M; Testori AAE; Foshag LJ; Van Kreuningen L; Wang HJ; Sim MS; Scolyer RA; Elashoff DE; Cochran AJ; Faries MB
JAMA Surg; 2022 Sep; 157(9):835-842. PubMed ID: 35921122
[TBL] [Abstract][Full Text] [Related]
7. Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective study.
Zhong J; Zou Z; Hu T; Sun W; Wang C; Yan W; Luo Z; Liu X; Xu Y; Chen Y
Clin Exp Med; 2023 Nov; 23(7):4003-4010. PubMed ID: 37300655
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Outcomes Between Surveillance Ultrasound and Completion Lymph Node Dissection in Children and Adolescents With Sentinel Lymph Node-Positive Cutaneous Melanoma.
Scoville SD; Stanek JR; Rinehardt H; Sutthatarn P; Abdelhafeez AH; Talbot LJ; Malek M; Leraas HJ; Tracy ET; Chen SY; Kim ES; Lotakis DM; Ehrlich PF; Favela JG; Le HD; Davidson J; Wilson CA; Seemann NM; Osman Y; Piche N; Hoang V; Petroze RT; Polites SF; McKay KG; Correa H; Lovvorn HN; Lee YM; Balagani A; Dasgupta R; Aldrink JH
Ann Surg; 2024 Mar; 279(3):536-541. PubMed ID: 37487006
[TBL] [Abstract][Full Text] [Related]
9. Is sentinel lymph node biopsy needed for lentigo maligna melanoma?
Kakish H; Lal T; Thuener JE; Bordeaux JS; Mangla A; Rothermel LD; Hoehn RS
J Surg Oncol; 2024 Mar; 129(4):804-812. PubMed ID: 38018361
[TBL] [Abstract][Full Text] [Related]
10. Investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey.
Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
J Plast Reconstr Aesthet Surg; 2024 Apr; 91():167-172. PubMed ID: 38417393
[TBL] [Abstract][Full Text] [Related]
11. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
Broman KK; Hughes TM; Bredbeck BC; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; O'shea K; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Hotz M; Farma JM; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley GM; Hui JYC; Been L; Kruijff S; Sinco B; Sarnaik AA; Sondak VK; Zager JS; Dossett LA;
Ann Surg; 2023 May; 277(5):e1106-e1115. PubMed ID: 35129464
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm).
Holmberg CJ; Mikiver R; Isaksson K; Ingvar C; Moncrieff M; Nielsen K; Ny L; Lyth J; Olofsson Bagge R
Ann Surg Oncol; 2023 Dec; 30(13):8026-8033. PubMed ID: 37574516
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center.
Namikawa K; Aung PP; Gershenwald JE; Milton DR; Prieto VG
Cancer Med; 2018 Mar; 7(3):583-593. PubMed ID: 29464914
[TBL] [Abstract][Full Text] [Related]
14. Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-Positive Sentinel Node Melanoma: The Role of the First Postoperative Ultrasound.
Keller J; Stern S; Chang SC; Marcus R; Weiss J; Nassoiy S; Christopher W; Fischer T; Essner R
Ann Surg Oncol; 2022 Dec; 29(13):8469-8477. PubMed ID: 35989390
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: A population-based analysis.
Sharon CE; Straker RJ; Gimotty PA; Chu EY; Mitchell TC; Miura JT; Marchetti MA; Bartlett EK; Karakousis GC
J Am Acad Dermatol; 2023 Apr; 88(4):802-807. PubMed ID: 36442639
[TBL] [Abstract][Full Text] [Related]
16. Omission of Completion Lymph Node Dissection in Sentinel Node Biopsy Positive Head and Neck Cutaneous Melanoma Patients.
Kesmodel SB; Kronenfeld JP; Zhao W; Koru-Sengul T; Goel N; Weingrad DN; Hernandez-Aya L; Lutzky J; Feun L; Garland-Kledzik M; Crystal JS
Ann Surg Oncol; 2023 Nov; 30(12):7671-7685. PubMed ID: 37639029
[TBL] [Abstract][Full Text] [Related]
17. Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.
Masoud SJ; Perone JA; Farrow NE; Mosca PJ; Tyler DS; Beasley GM
Curr Treat Options Oncol; 2018 Sep; 19(11):55. PubMed ID: 30232648
[TBL] [Abstract][Full Text] [Related]
18. Predictors of sentinel lymph node metastasis in very thin invasive melanomas.
Kakish H; Sun J; Zheng DX; Ahmed FA; Elshami M; Loftus AW; Ocuin LM; Ammori JB; Hoehn RS; Bordeaux JS; Rothermel LD
Br J Dermatol; 2023 Sep; 189(4):419-426. PubMed ID: 37290803
[TBL] [Abstract][Full Text] [Related]
19. Association between tumor-infiltrating lymphocytes and sentinel lymph node positivity in thin melanoma.
Santos FMD; Silva FCD; Pedron J; Furian RD; Fortes C; Bonamigo RR
An Bras Dermatol; 2019; 94(1):47-51. PubMed ID: 30726463
[TBL] [Abstract][Full Text] [Related]
20. Completely resected stage III melanoma controversy - 15 years of national tertiary centre experience.
Peric B; Milicevic S; Perhavec A; Hocevar M; Zgajnar J
Radiol Oncol; 2020 Oct; 55(1):50-56. PubMed ID: 33885234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]